213 related articles for article (PubMed ID: 32239430)
21. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma.
Chakhoyan A; Woodworth DC; Harris RJ; Lai A; Nghiemphu PL; Liau LM; Pope WB; Cloughesy TF; Ellingson BM
J Neurooncol; 2018 Sep; 139(3):651-659. PubMed ID: 29855771
[TBL] [Abstract][Full Text] [Related]
22. Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis.
Steed TC; Treiber JM; Patel K; Ramakrishnan V; Merk A; Smith AR; Carter BS; Dale AM; Chow LM; Chen CC
Oncotarget; 2016 May; 7(18):24899-907. PubMed ID: 27056901
[TBL] [Abstract][Full Text] [Related]
23. The association of subventricular zone involvement at recurrence with survival after repeat surgery in patients with recurrent glioblastoma.
Sonoda Y; Saito R; Kanamori M; Kumabe T; Uenohara H; Tominaga T
Neurol Med Chir (Tokyo); 2014; 54(4):302-9. PubMed ID: 24390189
[TBL] [Abstract][Full Text] [Related]
24. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.
Lee P; Eppinga W; Lagerwaard F; Cloughesy T; Slotman B; Nghiemphu PL; Wang PC; Kupelian P; Agazaryan N; Demarco J; Selch MT; Steinberg M; Kang JJ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):609-15. PubMed ID: 23462418
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.
Auer TA; Breit HC; Marini F; Renovanz M; Ringel F; Sommer CJ; Brockmann MA; Tanyildizi Y
J Neuroradiol; 2019 Feb; 46(1):36-43. PubMed ID: 29733920
[TBL] [Abstract][Full Text] [Related]
27. Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.
Buemi F; Guzzardi G; Del Sette B; Sponghini AP; Matheoud R; Soligo E; Trisoglio A; Carriero A; Stecco A
Neuroradiol J; 2019 Aug; 32(4):241-249. PubMed ID: 31066622
[TBL] [Abstract][Full Text] [Related]
28. Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlation.
Gollapalli K; Ghantasala S; Kumar S; Srivastava R; Rapole S; Moiyadi A; Epari S; Srivastava S
Sci Rep; 2017 May; 7(1):1449. PubMed ID: 28469129
[TBL] [Abstract][Full Text] [Related]
29. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
[TBL] [Abstract][Full Text] [Related]
30. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
[TBL] [Abstract][Full Text] [Related]
31. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.
Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS
Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055
[TBL] [Abstract][Full Text] [Related]
32. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
33. What is the role of the subventricular zone in radiotherapy of glioblastoma patients?
Bender K; Träger M; Wahner H; Onken J; Scheel M; Beck M; Ehret F; Budach V; Kaul D
Radiother Oncol; 2021 May; 158():138-145. PubMed ID: 33636228
[TBL] [Abstract][Full Text] [Related]
34. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
Weinberg BD; Boreta L; Braunstein S; Cha S
J Neurooncol; 2018 Jul; 138(3):549-556. PubMed ID: 29546530
[TBL] [Abstract][Full Text] [Related]
35. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlates of subventricular zone-contacting glioblastomas: a meta-analysis.
Mistry AM
J Neurosurg Sci; 2019 Oct; 63(5):581-587. PubMed ID: 29205011
[TBL] [Abstract][Full Text] [Related]
37. Subventricular zones: new key targets for glioblastoma treatment.
Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
[TBL] [Abstract][Full Text] [Related]
38. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
39. Defining subventricular zone involvement to predict the survival of patients in isocitrate dehydrogenase-wild type glioblastoma: validation in a prospective registry.
Kim JE; Park JE; Park SY; Kim YH; Hong CK; Kim JH; Kim HS
Eur Radiol; 2023 Sep; 33(9):6448-6458. PubMed ID: 37060448
[TBL] [Abstract][Full Text] [Related]
40. Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.
Mistry AM; Dewan MC; White-Dzuro GA; Brinson PR; Weaver KD; Thompson RC; Ihrie RA; Chambless LB
J Neurooncol; 2017 Apr; 132(2):341-349. PubMed ID: 28074322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
